As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


Pépinière Genopole Entreprises – 4, rue Pierre Fontaine
91058 EVRY Cedex – France
Phone: +33 1 69 47 77 25

Hervé CHERADAME: President & CEO
Site Web >
Polytheragene - Genopole's Company Polytheragene - Genopole's Company

#R&D Services and Products

  • Transfection
  • Gene therapy
  • Biomanufacturing
  • Therapeutic proteins
  • Vaccine

Field of Activity

Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing.
Cosmetic and therapeutic molecules from plant biomass.

The association of two complementary teams from the MPI/LAMBE laboratories at the University of Évry and the molecular biophysics laboratory at Orléans led to the development of two patented polymer families for nucleic acid transfection.
Two families of synthetic agents have been developed. The first is derived from polyethylenimine and the second is formed by amphiphilic triblock copolymers for in vitro and in vivo applications. These compounds offer better efficacy and lower toxicity than market references.
New formulas are currently under development at the MPI lab (UEVE).
Common research with biomanufacturers showed the high performances (high efficacy, low toxicity) of these vectors for biomanufacturing in large volumes (higher than 50L) (GMP quality available).
We are looking for partnerships and co-development opportunities with biomanufacturers, companies offering high throughput cell screening and biotechnology laboratories developing DNA or RNA vaccines. Companies interested in new molecules of therapeutic or cosmetic interest from plant biomass.

  • Further Information

    Annual turnover: Greater than €100,000
    1 exclusive license from the university of Évry
    2 staff members
    high performance synthetic vectors.
    Complementary teams in chemistry and biochemistry.
    Innovation assets:
    ability to develop high efficacy transfecting agents for specific applications (stem cells and cell suspension cultures).
    Other facts:
    new formulations for RNA transfer.

Genopole’s Companies

#R&D Services and Products

In the same field

Alt Biotech - Genopole's Company Gene.iO#3

Alt Biotech

Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact

Quibiotic - Projet Shaker


Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.

Maison M - Startup génopolitaine

Maison M

Personalized and sustainable Cosmetic House inspired by various and unique beauties. The innovative Maison M lipstick delivers any shade customized by its user.

Adlin - Entreprise génopolitaine - #IA Biotech

Adlin Science

ADLIN Science is a mission-driven company that strives to transform the life sciences sector by providing solutions to bring together public actors (institutes, hospitals, universities) and private actors (biotechs, pharma). Our innovative approach is to develop the first decentralized Digital Research Environment (fundamental, translational, and clinical) dedicated to the entire public and private ecosystem. ADLIN is the scientific trusted third-party among all actors in the sector with the ambition to accelerate innovation in healthcare while participating in research financing.

Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks


Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Xentech - Genopole Company


XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.

Phinc Development - Genopole's Company

PhinC Development

PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.

New england Biolabs - Genopole's Compny - 50 Years logo

New England Biolabs France

New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.

Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

logo abcell Bio - Genopole's Companie


Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

View all >
With the support from
Région île de France